Kathryn Evans Selected Research

Kathryn Evans Research Topics

Disease

16	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 04/2013
9	Leukemia 08/2023 - 04/2013
5	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 02/2024 - 09/2014
3	Neoplasms (Cancer) 12/2018 - 01/2016
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2023 - 01/2016
2	Hematologic Neoplasms (Hematological Malignancy) 08/2023 - 06/2023
2	Drug Resistant Epilepsy 01/2023 - 01/2023
1	COVID-19 12/2023
1	Epilepsy (Aura) 01/2023
1	Preleukemia 01/2023
1	Spinal Dysraphism (Spina Bifida) 01/2022
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2022
1	Endometriosis 01/2021
1	Chronic Pain 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019
1	Glucocorticoid Receptor Deficiency 12/2018
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2017
1	Rare Diseases (Rare Disease) 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2016
1	Hemorrhage 09/2014
1	Pain (Aches) 02/2013
1	Postoperative Nausea and Vomiting (PONV) 02/2013
1	Wilms Tumor (Wilm's Tumor) 12/2010
1	Infections 07/2006

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2014
2	Dynamins (Dynamin)IBA 02/2021 - 12/2020
2	ChromatinIBA 12/2019 - 12/2018
2	ProdrugsIBA 01/2019 - 09/2015
2	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 04/2013
2	navitoclaxIBA 01/2016 - 09/2014
1	ixazomibIBA 02/2024
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2024
1	UbiquitinIBA 02/2024
1	Proteasome InhibitorsIBA 02/2024
1	COVID-19 VaccinesIBA 12/2023
1	Phosphotransferases (Kinase)IBA 08/2023
1	duvelisibIBA 08/2023
1	LipidsIBA 08/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2023
1	TAK-659IBA 06/2023
1	Pimozide (Orap)FDA Link 01/2023
1	Interleukin-7 (Interleukin 7)IBA 01/2023
1	ruxolitinibIBA 11/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	dynole 34-2IBA 12/2020
1	GTP Phosphohydrolases (GTPases)IBA 12/2020
1	OT-82IBA 01/2020
1	VTP50469IBA 12/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	nelarabine (506U78)FDA Link 01/2019
1	GlucocorticoidsIBA 12/2018
1	RNA (Ribonucleic Acid)IBA 12/2018
1	human GALNS proteinIBA 01/2017
1	birinapantIBA 01/2016
1	venetoclaxIBA 01/2016
1	Asparaginase (Elspar)FDA Link 09/2015
1	PR-104IBA 09/2015
1	Mechlorethamine (Nitrogen Mustard)FDA Link 09/2015
1	EstersIBA 09/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015
1	Phosphates (Orthophosphate)IBA 09/2015
1	Vincristine (Oncovin)FDA LinkGeneric 09/2015
1	PR-104AIBA 09/2015
1	AZD 1480IBA 02/2015
1	Janus Kinase InhibitorsIBA 02/2015
1	Janus KinasesIBA 02/2015
1	coltuximab ravtansineIBA 04/2013
1	Maytansine (Maitansine)IBA 04/2013
1	Propofol (Diprivan)FDA LinkGeneric 02/2013
1	Sevoflurane (Ultane)FDA LinkGeneric 02/2013
1	Remifentanil (Ultiva)FDA Link 02/2013
1	Anesthetics (Anesthetic Agents)IBA 02/2013
1	Adenosine Monophosphate (AMP)IBA 07/2006

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2023 - 12/2020
4	Therapeutics 07/2017 - 04/2013
2	Pain Management 01/2021 - 02/2013
1	Ambulatory Care (Outpatient Care) 01/2023
1	Vagus Nerve Stimulation 01/2023
1	Conservative Treatment 01/2022
1	Enzyme Replacement Therapy 01/2017
1	Blood Transfusion (Blood Transfusions) 09/2014
1	Resuscitation 09/2014
1	Anesthesia 02/2013
1	Analgesia 02/2013
1	Intravenous Anesthesia 02/2013
1	Neoadjuvant Therapy 12/2010